Risultati di ricerca - Portale di modelli di dati medici (MDM-Portal)

Leukemia DRKS00003845 NCT00651261 Registration - CALGB: 10603 Registration Worksheet For Non-North American Sites - 2945236v1.0 - CALGB: 10603 Registration Worksheet For Non-North American Sites

- 20/09/21 - 1 modulo, 8 itemgroups, 37 elementi, 1 linguaggio

Itemgroups: Header Module, Protocol Administration, Patient Demographics/Pre-Treatment Characteristics1, Patient Demographics/Pre-Treatment Characteristics2, Certification Of Eligibility, Protocol Design, Companion Studies, Registration Information

CALGB: 10603 Registration Worksheet For Non-North American Sites Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=7456F79A-F2F6-BFB6-E040-BB89AD436544

Kidney Cancer NCT01198158 Registration - CALGB 90802 Registration Worksheet Form - 3103555v1.0 - CALGB 90802 Registration Worksheet Form

- 20/09/21 - 1 modulo, 10 itemgroups, 44 elementi, 1 linguaggio

Itemgroups: Header Module, Protocol Administration, Patient Demographics/Pre-Treatment Characteristics1, Patient Demographics/Pre-Treatment Characteristics2, Patient Demographics/Pre-Treatment Characteristics3, Certification Of Eligibility, Protocol Design, Initial Patient Consent For Specimen Use, CALGB 580902, Registration Information

CALGB 90802 Registration Worksheet Form Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=879626AD-DB8C-4AF2-E040-BB89AD4364E1

Lung Cancer NCT01041781 Registration - CALGB-30801 Registration Worksheet Form - 2891095v1.0 - CALGB-30801 Registration Worksheet Form

- 20/09/21 - 1 modulo, 9 itemgroups, 36 elementi, 1 linguaggio

Itemgroups: Header Module, Protocol Administration, Patient Demographics/Pre-Treatment Characteristics1, Patient Demographics/Pre-Treatment Characteristics2, Patient Demographics/Pre-Treatment Characteristics3, Certification Of Eligibility, Protocol Design, Companion Study, Registration Information

CALGB-30801 Registration Worksheet Form Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6AF26CA3-DB68-EEE0-E040-BB89AD436D54

Colon cancer (NSABP C-08 NCT00096278) - REGISTRATION FORM Colon cancer (NCT00096278)

- 20/09/21 - 1 modulo, 3 itemgroups, 64 elementi, 1 linguaggio

Itemgroups: Header, Patient characteristics, Eligibility Checklist

NSABP PROTOCOL C-08: REGISTRATION FORM Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer NCT00096278 Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=D7F6865F-B506-428D-E034-0003BA12F5E7

Breast Cancer NCT01275677 Registration - NSABP Protocol B-47 Worksheet for Form Entry - 3155372v1.0 - NSABP Protocol B-47 Worksheet for Form Entry

- 20/09/21 - 1 modulo, 11 itemgroups, 139 elementi, 1 linguaggio

Itemgroups: Header, Patient Consent, SECTION 1 - HER2 Status, SECTION 2 - Surgery and Pathology, Section 3 - Baseline Values (I), Section 3 - Baseline Values (II), Section 3 - Baseline Values (III), SECTION 3 - Baseline Values (IV), SECTION 4 - Patient History, SECTION 5 - Menopausal Status, Footer Module

NSABP Protocol B-47 Worksheet for Form Entry A Randomized Phase III Trial of Adjuvant Therapy Comparing Chemotherapy Alone (Six Cycles of Docetaxel Plus Cyclophosphamide or Four Cycles of Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel) to Chemotherapy Plus Trastuzumab in Women With Node- Positive or High-Risk Node-Negative HER2-Low Invasive Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=942D0C00-2D04-589C-E040-BB89AD433FFB

Registration Leukemia COG AALL08B1 NCT01142427

- 20/09/21 - 1 modulo, 9 itemgroups, 72 elementi, 1 linguaggio

Itemgroups: Stratification, PATIENT CRITERIA, Consents I, Exclusion Criteria, Organ Function - Non Hematological, Organ Function - Hematological, Inclusion Criteria, Stratification II, CONSENT FOR RESEARCH STUDIES

COG AALL08B1 OPEN Registration Worksheet NCT01142427 Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=ADF3C25C-AD44-CFB2-E040-BB89AD4343C8

First registration (DKKR)

- 20/09/21 - 1 modulo, 1 ItemGroup, 24 elementi, 2 lingue

ItemGroup: Administrative Documentation

German Pediatric Oncology Registry http://www.kinderkrebsregister.de

Pre-Randomization Colon Cancer Stage III N0147 NCT00079274

- 20/09/21 - 1 modulo, 12 itemgroups, 70 elementi, 1 linguaggio

Itemgroups: Header module, Visit, Protocol Administration, Patient Demographics/Pre-Treatment Characteristics, KRAS Results Contact, KRAS Results Contact (alternate), Eligibility Check, Contraindications, Pre-Randomization Check, The following will also be recorded:, The following will also be recorded:, Protocol Design

Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=70E10B08-8A7D-A35C-E040-BB89AD432A74

Pancreatic Cancer NCT00733746 Registration - ACOSOG-Z5041 Registration Worksheet - 2921129v1.0 - ACOSOG-Z5041 Registration Worksheet

- 20/09/21 - 1 modulo, 4 itemgroups, 34 elementi, 1 linguaggio

Itemgroups: Header Module, Eligibility Criteria, Diagnosis and Therapy, Specimen Banking Consent

ACOSOG-Z5041 Registration Worksheet Gemcitabine and Erlotinib Before and After Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6F3D4C5B-FB42-7755-E040-BB89AD432E97

CALGB COOPERATIVE GROUP ADJUVANT BREAST CANCER RANDOMIZATION NCT00016276

- 20/09/21 - 1 modulo, 4 itemgroups, 38 elementi, 1 linguaggio

Itemgroups: CALGB Information, PROTOCOL ADMINISTRATION, PATIENT DEMOGRAPHICS / PRE u TREATMENT CHARACTERISTICS, STRATIFICATION FACTORS

CALGB COOPERATIVE GROUP ADJUVANT BREAST CANCER RANDOMIZATION NCT00016276 Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=9E35395C-8542-227A-E034-080020C9C0E0

Registration Worksheet Breast Cancer Z1041 NCT00513292

- 20/09/21 - 1 modulo, 13 itemgroups, 81 elementi, 1 linguaggio

Itemgroups: Header Module, Patient Information, Consent, Inclusion Criteria, Exclusion Criteria, Eligibility Assessment, Method of Evaluation, Pregnancy Test, Primary Tumor Biopsy, Clinical Stage, Laboratory Values, History, Footer

Z1041: Registration Worksheet NCT00513292 Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=211E7BC7-C479-7160-E044-0003BA3F9857

CALGB 140503 PRE-REGISTRATION WORKSHEET

- 20/09/21 - 1 modulo, 3 itemgroups, 20 elementi, 1 linguaggio

Itemgroups: Protocol Administration, Patient Demographics/Pre-Treatment Characteristics, Notes:

CALGB 140503 PRE-REGISTRATION WORKSHEET Comparison of Different Types of Surgery in Treating Patients With Stage IA Non-Small Cell Lung Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6E4AB7DA-A34F-776C-E040-BB89AD430B3B

Keywords

Sommario

Modelli di dati selezionati